Clobazam Suspension
Product Images NDC 72162-2608
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 72162-2608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-10 (Clobazam Fig10)
Figure-11 (Clobazam Fig11)
Figure (Clobazam Fig2)
Figure-3 (Clobazam Fig3)
Figure-4 (Clobazam Fig4)
Figure-5 (Clobazam Fig5)
Figure-6 (Clobazam Fig6)
Figure-7 (Clobazam Fig7)
Figure-4 (Clobazam Fig8)
Figure-9 (Clobazam Fig9)
Chemical Structure (Clobazam Str)
Label (Lbl721622608)
This is a description of an oral suspension liquid containing 2.5 mg of Clobazam per mL, supplied with two 10 mL syringes for administration. The product is recommended to be stored at 20° to 25°C (68° to 77°F) and should be shaken well before each use. The pharmacist is advised to provide the Medication Guide and Instructions for Use to each patient. The oral suspension should be stored in the original container in an upright position and used within 90 days of opening, discarding any remaining liquid after that time.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.